O Abe
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Risks and Factors
- Global Cancer Incidence and Screening
Papers in ⓘ
- Co-authors
- Rory Collins (1 shared paper)Marc Buyse (1 shared paper)Francesco Boccardo (1 shared paper)Martin D. Abeloff (1 shared paper)David L. Ahmann (1 shared paper)Paul P. Carbone (1 shared paper)Rosalin Cooper (1 shared paper)J. Carpenter (1 shared paper)
- Journals
- The Journal of Clinical Endocrinology & Metabolism (1 paper)Biomedicine & Pharmacotherapy (1 paper)The Breast (1 paper)International Journal of Immunopharmacology (1 paper)Kansenshogaku zasshi (1 paper)
- Partner nations
- JapanUnited KingdomUnited States
In The Last Decade
O Abe
45 papers receiving 701 citations
Peers
Comparison fields: 5 of 92
- Cancer Research 270
- Oncology 336
- Genetics 258
- Pathology and Forensic Medicine 80
- Reproductive Medicine 35
Countries citing papers authored by O Abe
This map shows the geographic impact of O Abe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O Abe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O Abe more than expected).
Fields of papers citing papers by O Abe
This network shows the impact of papers produced by O Abe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O Abe. The network helps show where O Abe may publish in the future.
Co-authors
The 25 scholars most cited alongside O Abe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women | 1988 | 481 |
| 2 | 1968 | 39 | |
| 3 | 1976 | 37 | |
| 4 | 1976 | 27 | |
| 5 | [Studies on the effect of lentinan on human immune system. II. In vivo effect on NK activity, MLR induced killer activity and PHA induced blastic response of lymphocytes in cancer patients]. | 1983 | 16 |
| 6 | 1976 | 14 | |
| 7 | 1979 | 12 | |
| 8 | Endogenous urinary 3-hydroxyproline has 96% specificity and 44% sensitivity for cancer screening. | 1992 | 9 |
| 9 | [Initial basic and clinical evaluation of a solid-phase immunoradiometric assay for sialyl SSEA-1 antigen: 1. Evaluation of assay conditions and normal values]. | 1987 | 8 |
| 10 | 1989 | 7 | |
| 11 | Targeted killing of squamous carcinoma cells by a monoclonal antibody-peplomycin conjugate which recognizes the EGF receptor. | 1992 | 7 |
| 12 | [Initial basic and clinical evaluation of a solid-phase immunoradiometric assay for sialyl SSEA-1 antigen: 2. Evaluation of clinical significance]. | 1987 | 7 |
| 13 | [A multi-institutional study on postoperative adjuvant immunochemotherapy of gastric cancer (II)]. | 1985 | 6 |
| 14 | [Experimental chemotherapy of human carcinomas serially transplanted to nude mice--an evaluation of the Battelle Columbus Laboratories Protocol (author's transl)]. | 1980 | 6 |
| 15 | 1977 | 6 | |
| 16 | [Combination chemotherapy of cyclophosphamide adriamycin and 5-fluorouracil (CAF) in advanced and recurrent breast cancer]. | 1982 | 5 |
| 17 | [Selective hepatic arterial infusion of liposomes containing antitumor agents]. | 1985 | 5 |
| 18 | [Phase II study of NK 622 (toremifene citrate) in advanced breast cancer, a multicentral cooperative dose finding study]. | 1993 | 4 |
| 19 | [Clinical evaluation on an enzyme immunoassay kit for basic fetoprotein (BFP). (1) Clinical usefulness of BFP]. | 1988 | 3 |
| 20 | [Phase I study of FK 435]. | 1990 | 3 |
About O Abe
O Abe is a scholar working on Genetics, Oncology, Pulmonary and Respiratory Medicine, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 45 papers that have together received 736 indexed citations. Recurring topics across this work include Estrogen and related hormone effects (12 papers), Gastric Cancer Management and Outcomes (6 papers), Cancer Treatment and Pharmacology (4 papers), Gastrointestinal Tumor Research and Treatment (4 papers), Metastasis and carcinoma case studies (4 papers), Breast Cancer Treatment Studies (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). The work is most often cited by research in Cancer Research (270 citations), Oncology (336 citations), Genetics (258 citations), Pathology and Forensic Medicine (80 citations) and Reproductive Medicine (35 citations). O Abe has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include Rory Collins, Marc Buyse, Francesco Boccardo, Martin D. Abeloff, David L. Ahmann, Paul P. Carbone, Rosalin Cooper, J. Carpenter, Andrea Bianco and R. T. Chlebowski. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Biomedicine & Pharmacotherapy, The Breast, International Journal of Immunopharmacology and Kansenshogaku zasshi.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.